<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

The Ultimate Guide to Mouse Clinical Trials

The cost of bringing a new drug to market carries a high price, however it is even more costly when that drug fails during late stage clinical trials. An estimated 95% of new drug candidates fail clinical trials with 50% of these failures attributed to a lack of efficacy and downstream biomarker discovery.